1. GRP-023 Anti-Factor Xa Activity After Prophylactic Doses of Enoxaparin (40 mg) in Hospitalised Patients Weighing Less Than 55 Kilogrammes. (12th March 2013) Authors: Rojas, L; Aizman, A; Ernst, D; Acuña, MP; Moya, P; Mellado, R Journal: European journal of hospital pharmacy Issue: Volume 20(2013)Supplement 1 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗